Search Results - Hara-Cleaver, Claire

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial

    Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFF... by Nakamura, Kunio, Sun, Zhaonan, Hara-Cleaver, Claire, Bodhinathan, Karthik, Avila, Robin L

    Published in Multiple sclerosis
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Early tolerability and safety of fingolimod in clinical practice

    Early tolerability and safety of fingolimod in clinical practice by Ontaneda, Daniel, Hara-Cleaver, Claire, Rudick, Richard A, Cohen, Jeffrey A, Bermel, Robert A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up

    Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up by Hersh, Carrie M, Love, Thomas E, Cohn, Samuel, Hara-Cleaver, Claire, Bermel, Robert A, Fox, Robert J, Cohen, Jeffrey A, Ontaneda, Daniel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Experience with fingolimod in clinical practice

    Experience with fingolimod in clinical practice by Hersh, Carrie M., Hara-Cleaver, Claire, Rudick, Richard A., Cohen, Jeffrey A., Bermel, Robert A., Ontaneda, Daniel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up

    Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up by Hersh, Carrie M, Love, Thomas E, Bandyopadhyay, Anasua, Cohn, Samuel, Hara-Cleaver, Claire, Bermel, Robert A, Fox, Robert J, Cohen, Jeffrey A, Ontaneda, Daniel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Technology-enabled assessments to enhance multiple sclerosis clinical care and research

    Technology-enabled assessments to enhance multiple sclerosis clinical care and research by Macaron, Gabrielle, Moss, Brandon P., Li, Hong, Baldassari, Laura E., Rao, Stephen M., Schindler, David, Alberts, Jay L., Weber, Malory, Ayers, Malissa, Bethoux, François, Boissy, Adrienne, Chizmadia, Desiree, Conway, Devon S., Fink, Charlene, Fox, Robert J., Gales, Shauna, Green, Bethany, Hara-Cleaver, Claire, Jordan, Neal, Mahajan, Kedar R., McGinley, Marisa P., Miller, Deborah M., Namey, Marie, Rae-Grant, Alexander, Rensel, Mary, Young, Hilary, Willis, Mary A., Ontaneda, Daniel, Cohen, Jeffrey A., Bermel, Robert A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: